Hannah T. Sang

Also affiliated with The University of Texas Medical Branch at Galveston

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Targeting the MYCN-MDM2 pathways for cancer therapy: Are they druggable?”.

Targeting the MYCN-MDM2 pathways for cancer therapy: Are they druggable?

Genes & Diseases(2023)10.1016/j.gendis.2023.101156

N/A

0DataRank · unranked

7 citations

Yi Du, Sayantap Datta, Josef F. Fowler, Hannah T. Sang, Najah Albadari +4 more

MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future

Pharmacological Reviews(2024)10.1124/pharmrev.123.001026

N/A

0DataRank · unranked

127 citations

Najah Albadari, Yi Du, Josef F. Fowler, Hannah T. Sang, Wa Xian +5 more